Copyright
©The Author(s) 2026.
World J Hepatol. Jan 27, 2026; 18(1): 111871
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111871
Published online Jan 27, 2026. doi: 10.4254/wjh.v18.i1.111871
Figure 1 PRISMA flowchart showing study identification and selection process.
Figure 2 Impact of clinically significant portal hypertension on postoperative outcomes of patients in the included studies.
A: Posthe patectomy liver failure (PHLF); B: PHLF in Child-Pugh A stage patients; C: Stratified meta-analysis of PHLF (the diagnostic methods used for clinically significant portal hypertension). CSPH: Clinically significant portal hypertension; CI: Confidence interval.
- Citation: Ruan MH, Ye FY, Ma JN, Qian J, Zou MH, Zhou WX, Sheng J, Guo XG, Wei D, Zhang CJ, Liu H, Liu FC. Impact of clinically significant portal hypertension on posthepatectomy liver failure: A systematic review and meta-analysis. World J Hepatol 2026; 18(1): 111871
- URL: https://www.wjgnet.com/1948-5182/full/v18/i1/111871.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i1.111871
